Compare Immunovant Inc. Common Stock (IMVT) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Waste Management, Inc. — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Waste Management, Inc. trades at $208.3 (market cap $83.52B). The key difference: Waste Management, Inc. is far larger — about 12.6× Immunovant Inc. Common Stock's market cap, and Waste Management, Inc. pays a 1.81% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Waste Management, Inc. for 130 Days on average.
| IMVT | WM | |
|---|---|---|
Market Cap | $6.62B | $83.52B |
Volume | 1,131,364 | 2,257,928 |
Sector | Health | Industrials |
52-Week High | $44.96 | $246.51 |
52-Week Low | $17.03 | $196.77 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $5.72B | $106.32B |
Dividend Yield | — | 1.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WM trades at $210.10, up 1.07% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with $25.2B revenue, 11.12% net margin, and robust cash flow generation. Recent earnings show two beats out of three quarters, while analyst consensus remains strongly positive with 57% buy ratings and no sell recommendations.
WM presents a compelling long-term investment with defensive business model and consistent profitability, though elevated debt levels and valuation multiples require monitoring. The stock offers dividend income with recent $0.95 payout, supported by pricing power and network scale advantages in the essential waste management industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
